SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-003165
Filing Date
2024-01-22
Accepted
2024-01-22 17:10:16
Documents
14
Period of Report
2024-01-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20019392_8k.htm   iXBRL 8-K 30719
2 EXHIBIT 10.1 ef20019392_ex10-1.htm EX-10.1 51185
3 EXHIBIT 99.1 ef20019392_ex99-1.htm EX-99.1 18495
  Complete submission text file 0001140361-24-003165.txt   257748

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20240122.xsd EX-101.SCH 3872
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20240122_lab.xml EX-101.LAB 22547
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20240122_pre.xml EX-101.PRE 16049
8 EXTRACTED XBRL INSTANCE DOCUMENT ef20019392_8k_htm.xml XML 4076
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 24549679
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)